The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Colorectal Cancer Screening Market Research Report 2025
Synopsis
Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease.
The global Colorectal Cancer Screening market was valued at US$ 644.2 million in 2023 and is anticipated to reach US$ 788.6 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
North American market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Colorectal Cancer Screening in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Screening.
Report Scope
The Colorectal Cancer Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Clinical Genomics Technologies
Epigenomics Inc
Exact Sciences
Roche
Hemosure Inc
Novigenix SA
Quidel
Siemens
Sysmex
Segment by Type
Stool-based Tests
Colonoscopy
CT Colonography
Others
Segment by Application
Hospitals
Independent Diagnostic Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease.
The global Colorectal Cancer Screening market was valued at US$ 644.2 million in 2023 and is anticipated to reach US$ 788.6 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
North American market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Colorectal Cancer Screening in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Screening.
Report Scope
The Colorectal Cancer Screening market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Colorectal Cancer Screening market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Screening companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Clinical Genomics Technologies
Epigenomics Inc
Exact Sciences
Roche
Hemosure Inc
Novigenix SA
Quidel
Siemens
Sysmex
Segment by Type
Stool-based Tests
Colonoscopy
CT Colonography
Others
Segment by Application
Hospitals
Independent Diagnostic Labs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Colorectal Cancer Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Screening Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stool-based Tests
1.2.3 Colonoscopy
1.2.4 CT Colonography
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Screening Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Independent Diagnostic Labs
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Screening Market Perspective (2019-2030)
2.2 Colorectal Cancer Screening Growth Trends by Region
2.2.1 Global Colorectal Cancer Screening Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Colorectal Cancer Screening Historic Market Size by Region (2019-2024)
2.2.3 Colorectal Cancer Screening Forecasted Market Size by Region (2025-2030)
2.3 Colorectal Cancer Screening Market Dynamics
2.3.1 Colorectal Cancer Screening Industry Trends
2.3.2 Colorectal Cancer Screening Market Drivers
2.3.3 Colorectal Cancer Screening Market Challenges
2.3.4 Colorectal Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Screening Players by Revenue
3.1.1 Global Top Colorectal Cancer Screening Players by Revenue (2019-2024)
3.1.2 Global Colorectal Cancer Screening Revenue Market Share by Players (2019-2024)
3.2 Global Colorectal Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Screening Revenue
3.4 Global Colorectal Cancer Screening Market Concentration Ratio
3.4.1 Global Colorectal Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Screening Revenue in 2023
3.5 Colorectal Cancer Screening Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Screening Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Screening Breakdown Data by Type
4.1 Global Colorectal Cancer Screening Historic Market Size by Type (2019-2024)
4.2 Global Colorectal Cancer Screening Forecasted Market Size by Type (2025-2030)
5 Colorectal Cancer Screening Breakdown Data by Application
5.1 Global Colorectal Cancer Screening Historic Market Size by Application (2019-2024)
5.2 Global Colorectal Cancer Screening Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Colorectal Cancer Screening Market Size (2019-2030)
6.2 North America Colorectal Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Colorectal Cancer Screening Market Size by Country (2019-2024)
6.4 North America Colorectal Cancer Screening Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Screening Market Size (2019-2030)
7.2 Europe Colorectal Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Colorectal Cancer Screening Market Size by Country (2019-2024)
7.4 Europe Colorectal Cancer Screening Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Screening Market Size (2019-2030)
8.2 Asia-Pacific Colorectal Cancer Screening Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Colorectal Cancer Screening Market Size by Region (2019-2024)
8.4 Asia-Pacific Colorectal Cancer Screening Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Screening Market Size (2019-2030)
9.2 Latin America Colorectal Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Colorectal Cancer Screening Market Size by Country (2019-2024)
9.4 Latin America Colorectal Cancer Screening Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Screening Market Size (2019-2030)
10.2 Middle East & Africa Colorectal Cancer Screening Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Colorectal Cancer Screening Market Size by Country (2019-2024)
10.4 Middle East & Africa Colorectal Cancer Screening Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Colorectal Cancer Screening Introduction
11.1.4 Abbott Revenue in Colorectal Cancer Screening Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Clinical Genomics Technologies
11.2.1 Clinical Genomics Technologies Company Detail
11.2.2 Clinical Genomics Technologies Business Overview
11.2.3 Clinical Genomics Technologies Colorectal Cancer Screening Introduction
11.2.4 Clinical Genomics Technologies Revenue in Colorectal Cancer Screening Business (2019-2024)
11.2.5 Clinical Genomics Technologies Recent Development
11.3 Epigenomics Inc
11.3.1 Epigenomics Inc Company Detail
11.3.2 Epigenomics Inc Business Overview
11.3.3 Epigenomics Inc Colorectal Cancer Screening Introduction
11.3.4 Epigenomics Inc Revenue in Colorectal Cancer Screening Business (2019-2024)
11.3.5 Epigenomics Inc Recent Development
11.4 Exact Sciences
11.4.1 Exact Sciences Company Detail
11.4.2 Exact Sciences Business Overview
11.4.3 Exact Sciences Colorectal Cancer Screening Introduction
11.4.4 Exact Sciences Revenue in Colorectal Cancer Screening Business (2019-2024)
11.4.5 Exact Sciences Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Screening Introduction
11.5.4 Roche Revenue in Colorectal Cancer Screening Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Hemosure Inc
11.6.1 Hemosure Inc Company Detail
11.6.2 Hemosure Inc Business Overview
11.6.3 Hemosure Inc Colorectal Cancer Screening Introduction
11.6.4 Hemosure Inc Revenue in Colorectal Cancer Screening Business (2019-2024)
11.6.5 Hemosure Inc Recent Development
11.7 Novigenix SA
11.7.1 Novigenix SA Company Detail
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Colorectal Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Colorectal Cancer Screening Business (2019-2024)
11.7.5 Novigenix SA Recent Development
11.8 Quidel
11.8.1 Quidel Company Detail
11.8.2 Quidel Business Overview
11.8.3 Quidel Colorectal Cancer Screening Introduction
11.8.4 Quidel Revenue in Colorectal Cancer Screening Business (2019-2024)
11.8.5 Quidel Recent Development
11.9 Siemens
11.9.1 Siemens Company Detail
11.9.2 Siemens Business Overview
11.9.3 Siemens Colorectal Cancer Screening Introduction
11.9.4 Siemens Revenue in Colorectal Cancer Screening Business (2019-2024)
11.9.5 Siemens Recent Development
11.10 Sysmex
11.10.1 Sysmex Company Detail
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Colorectal Cancer Screening Introduction
11.10.4 Sysmex Revenue in Colorectal Cancer Screening Business (2019-2024)
11.10.5 Sysmex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Colorectal Cancer Screening Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Stool-based Tests
Table 3. Key Players of Colonoscopy
Table 4. Key Players of CT Colonography
Table 5. Key Players of Others
Table 6. Global Colorectal Cancer Screening Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Colorectal Cancer Screening Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Colorectal Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Colorectal Cancer Screening Market Share by Region (2019-2024)
Table 10. Global Colorectal Cancer Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Colorectal Cancer Screening Market Share by Region (2025-2030)
Table 12. Colorectal Cancer Screening Market Trends
Table 13. Colorectal Cancer Screening Market Drivers
Table 14. Colorectal Cancer Screening Market Challenges
Table 15. Colorectal Cancer Screening Market Restraints
Table 16. Global Colorectal Cancer Screening Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Colorectal Cancer Screening Market Share by Players (2019-2024)
Table 18. Global Top Colorectal Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening as of 2023)
Table 19. Ranking of Global Top Colorectal Cancer Screening Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Screening Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Colorectal Cancer Screening Product Solution and Service
Table 23. Date of Enter into Colorectal Cancer Screening Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Colorectal Cancer Screening Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Colorectal Cancer Screening Revenue Market Share by Type (2019-2024)
Table 27. Global Colorectal Cancer Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Colorectal Cancer Screening Revenue Market Share by Type (2025-2030)
Table 29. Global Colorectal Cancer Screening Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Colorectal Cancer Screening Revenue Market Share by Application (2019-2024)
Table 31. Global Colorectal Cancer Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Colorectal Cancer Screening Revenue Market Share by Application (2025-2030)
Table 33. North America Colorectal Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Colorectal Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Colorectal Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Colorectal Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Colorectal Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Colorectal Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Colorectal Cancer Screening Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Colorectal Cancer Screening Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Colorectal Cancer Screening Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Colorectal Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Colorectal Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Colorectal Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Colorectal Cancer Screening Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Colorectal Cancer Screening Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Colorectal Cancer Screening Market Size by Country (2025-2030) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Colorectal Cancer Screening Product
Table 51. Abbott Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Clinical Genomics Technologies Company Detail
Table 54. Clinical Genomics Technologies Business Overview
Table 55. Clinical Genomics Technologies Colorectal Cancer Screening Product
Table 56. Clinical Genomics Technologies Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 57. Clinical Genomics Technologies Recent Development
Table 58. Epigenomics Inc Company Detail
Table 59. Epigenomics Inc Business Overview
Table 60. Epigenomics Inc Colorectal Cancer Screening Product
Table 61. Epigenomics Inc Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 62. Epigenomics Inc Recent Development
Table 63. Exact Sciences Company Detail
Table 64. Exact Sciences Business Overview
Table 65. Exact Sciences Colorectal Cancer Screening Product
Table 66. Exact Sciences Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 67. Exact Sciences Recent Development
Table 68. Roche Company Detail
Table 69. Roche Business Overview
Table 70. Roche Colorectal Cancer Screening Product
Table 71. Roche Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Hemosure Inc Company Detail
Table 74. Hemosure Inc Business Overview
Table 75. Hemosure Inc Colorectal Cancer Screening Product
Table 76. Hemosure Inc Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 77. Hemosure Inc Recent Development
Table 78. Novigenix SA Company Detail
Table 79. Novigenix SA Business Overview
Table 80. Novigenix SA Colorectal Cancer Screening Product
Table 81. Novigenix SA Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 82. Novigenix SA Recent Development
Table 83. Quidel Company Detail
Table 84. Quidel Business Overview
Table 85. Quidel Colorectal Cancer Screening Product
Table 86. Quidel Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 87. Quidel Recent Development
Table 88. Siemens Company Detail
Table 89. Siemens Business Overview
Table 90. Siemens Colorectal Cancer Screening Product
Table 91. Siemens Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 92. Siemens Recent Development
Table 93. Sysmex Company Detail
Table 94. Sysmex Business Overview
Table 95. Sysmex Colorectal Cancer Screening Product
Table 96. Sysmex Revenue in Colorectal Cancer Screening Business (2019-2024) & (US$ Million)
Table 97. Sysmex Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Screening Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Colorectal Cancer Screening Market Share by Type: 2023 VS 2030
Figure 3. Stool-based Tests Features
Figure 4. Colonoscopy Features
Figure 5. CT Colonography Features
Figure 6. Others Features
Figure 7. Global Colorectal Cancer Screening Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Colorectal Cancer Screening Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Independent Diagnostic Labs Case Studies
Figure 11. Others Case Studies
Figure 12. Colorectal Cancer Screening Report Years Considered
Figure 13. Global Colorectal Cancer Screening Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Colorectal Cancer Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Colorectal Cancer Screening Market Share by Region: 2023 VS 2030
Figure 16. Global Colorectal Cancer Screening Market Share by Players in 2023
Figure 17. Global Top Colorectal Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Colorectal Cancer Screening Revenue in 2023
Figure 19. North America Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Colorectal Cancer Screening Market Share by Country (2019-2030)
Figure 21. United States Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Colorectal Cancer Screening Market Share by Country (2019-2030)
Figure 25. Germany Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Colorectal Cancer Screening Market Share by Region (2019-2030)
Figure 33. China Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Colorectal Cancer Screening Market Share by Country (2019-2030)
Figure 41. Mexico Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Colorectal Cancer Screening Market Share by Country (2019-2030)
Figure 45. Turkey Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Colorectal Cancer Screening Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 48. Clinical Genomics Technologies Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 49. Epigenomics Inc Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 50. Exact Sciences Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 52. Hemosure Inc Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 53. Novigenix SA Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 54. Quidel Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 55. Siemens Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 56. Sysmex Revenue Growth Rate in Colorectal Cancer Screening Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
